At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 26 enrolled
Drug / intervention
clindamycin phosphate 1.2% and tretinoin 0.025% +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adherence to ZIANA (Clindamycin Phosphate 1.2% With Tretinoin 0.025%)Gel Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris
In Brief
A Phase 4 clinical trial evaluating clindamycin phosphate 1.2% and tretinoin 0.025%, clindamycin 1% gel, and 1 other intervention for Acne Vulgaris. Completed, enrolled 26 participants across 1 site.
Detailed Summary
The purpose of this research study is to evaluate the effectiveness of two different types of topical acne medication. This study will help to determine if one combined medication results in better acne improvement than two separate medications for acne.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
CollaboratorsMedicis Pharmaceutical Corporation
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
Primary CompletionOct 2009
First PostedJan 2010
TodayJul 2026
First PostedJan 12, 2010
Enrollment StartMar 1, 2009
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 16.5 years ago
Interventions
clindamycin phosphate 1.2% and tretinoin 0.025%drug
applied once daily for 12 weeks
clindamycin 1% geldrug
Topical clindamycin applied each morning for 12 weeks
tretinoin 0.025% creamdrug
Tretinoin 0.025% cream each evening for 12 weeks